Stimulating questions and discussion with Clark Chen
Wafik S. El-Deiry shared on LinkedIn:
“Outstanding meeting yesterday afternoon of the CNS Cancer Translational Research Disease Group with a fantastic presentation by our colleague Clark Chen, MD, PhD, Professor at Brown University Neurosurgery.
Dr. Chen spoke about “Neuro-modulation as a Glioblastoma Therapeutic Platform” including elegant genetic screens while at Harvard Medicine, key cellular pathways, dopamine receptors, EGFR, and biophysical approaches. He published a great paper in Oncotarget a few years ago.
The discussions and questions were quite stimulating.”
Source: Wafik S. El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.
He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023